Published April 6, 2026 · Updated monthly
The Cheapest Prescription Drugs by Class: A Complete Price Guide (2026)
The same condition can be treated by drugs costing $5.00 per claim or $5,000.00 per claim — and often the cheap option works just as well. This guide breaks down the cheapest prescription drug in every major therapeutic class using Medicare Part D data across 11 drug classes, so you can have an informed conversation with your doctor about lower-cost alternatives.
Why Drug Class Matters More Than Drug Name
A drug class is a group of medications that work through the same mechanism to treat the same conditions. Statins all lower cholesterol by blocking an enzyme in the liver. SSRIs all treat depression by increasing serotonin levels. ACE inhibitors all lower blood pressure by blocking the same enzyme.
The critical insight: within a single class, prices can vary by 10x to 100x depending on whether a drug is still under patent or available as a generic. A brand-name statin might cost $400 per claim while generic atorvastatin costs $8. They treat the same condition through the same mechanism — but one costs 50 times more.
Understanding drug classes gives you leverage. When your doctor prescribes a brand-name medication, you can ask: "Is there a generic alternative in the same class?" In many cases, the answer is yes — and the savings are enormous.
Multiple Sclerosis (MS) Treatments
Disease-modifying therapies (DMTs) that slow MS progression, including infusions, oral medications, and injectables.
Cheapest Option
Generic dimethyl fumarate (Tecfidera generic)
$800.00/claim
Most Expensive
Ocrevus
$23,635.00/claim
Potential savings: $22,835.00 per claim by choosing the cheapest option
The cheapest option in this class is Generic dimethyl fumarate (Tecfidera generic) at $800.00 per claim — a generic that is widely available and well-established. The most expensive option, Ocrevus, costs $23,635.00 per claim. MS drugs are among the most expensive chronic medications. Tecfidera went generic in 2020, dropping from $7,000 to ~$800/month. Ocrevus ($23,635/claim) has no generic and won't until its patents expire around 2028. Generic Gilenya launched in 2022. See all Multiple Sclerosis (MS) Treatments drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Cancer Immunotherapy & Targeted Therapy
Checkpoint inhibitors, kinase inhibitors, and other precision cancer treatments. The highest-cost drug class by average price per claim.
Cheapest Option
Generic ibrutinib (Imbruvica biosimilar)
$6,500.00/claim
Most Expensive
Keytruda
$18,176.00/claim
Potential savings: $11,676.00 per claim by choosing the cheapest option
Generic ibrutinib (Imbruvica biosimilar) is the most affordable option at $6,500.00 per claim. At the other end, Keytruda costs $18,176.00 per claim. Cancer drugs average $11,461 per claim — 50x the average for all drugs. Generic competition is limited but growing: Ibrance went generic in 2024, and Revlimid faces generic entry. Medicare spent $92.5B on cancer drugs tracked here. See all Cancer Immunotherapy & Targeted Therapy drugs and prices →
When the cheaper option may not work: This class treats serious conditions where specific drug selection is critical. Your doctor may need to prescribe a particular drug based on your specific diagnosis, resistance testing, or treatment history. Do not switch without medical guidance.
Biologics for Autoimmune Diseases
TNF inhibitors, IL inhibitors, and JAK inhibitors used to treat rheumatoid arthritis, psoriasis, Crohn's disease, and other autoimmune conditions.
Cheapest Option
Humira biosimilars (Hadlima, Hyrimoz, etc.)
$1,200.00/claim
Most Expensive
Stelara
$7,763.00/claim
Potential savings: $6,563.00 per claim by choosing the cheapest option
Humira biosimilars (Hadlima, Hyrimoz, etc.) is the most affordable option at $1,200.00 per claim. At the other end, Stelara costs $7,763.00 per claim. 22 Humira biosimilars are now available, with prices 5-85% below brand Humira ($3,414/claim). 9 Stelara biosimilars launched in 2025-2026. The biosimilar wave is projected to save Medicare $100B+ over the next decade. See all Biologics for Autoimmune Diseases drugs and prices →
When the cheaper option may not work: Biologics in this class are not interchangeable without medical supervision. If you are stable on a specific biologic, switching to save money could trigger a disease flare. Discuss biosimilar alternatives with your specialist.
Asthma & COPD Inhalers
Inhaled corticosteroids, long-acting bronchodilators, combination inhalers, and biologic add-on therapies for asthma and chronic obstructive pulmonary disease.
Cheapest Option
Generic albuterol inhaler
$25.00/claim
Most Expensive
Nucala
$2,720.00/claim
Potential savings: $2,695.00 per claim by choosing the cheapest option
The cheapest option in this class is Generic albuterol inhaler at $25.00 per claim — a generic that is widely available and well-established. The most expensive option, Nucala, costs $2,720.00 per claim. Generic Symbicort launched in 2025, cutting costs from $222 to ~$50/month. Trelegy ($380/claim) has no generic yet. Biologic add-ons (Nucala $2,720, Xolair $1,657) are reserved for severe cases. Total Medicare respiratory spending exceeds $10B. See all Asthma & COPD Inhalers drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Antidepressants (SSRIs, SNRIs & Newer Agents)
Selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and newer treatments for depression and anxiety.
Cheapest Option
Sertraline (generic Zoloft)
$4.00/claim
Most Expensive
Spravato
$1,839.00/claim
Potential savings: $1,835.00 per claim by choosing the cheapest option
The cheapest option in this class is Sertraline (generic Zoloft) at $4.00 per claim — a generic that is widely available and well-established. The most expensive option, Spravato, costs $1,839.00 per claim. Generic SSRIs cost $4-20/month and are equally effective as brand-name versions for most patients. Spravato ($1,839/claim) is reserved for treatment-resistant depression — it requires in-office administration and monitoring. See all Antidepressants (SSRIs, SNRIs & Newer Agents) drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
HIV Antiretrovirals
Single-tablet regimens (STRs) and combination antiretroviral therapies that suppress HIV viral load to undetectable levels.
Cheapest Option
Generic Triumeq (dolutegravir/abacavir/lamivudine)
$2,800.00/claim
Most Expensive
Biktarvy
$3,746.00/claim
Potential savings: $946.00 per claim by choosing the cheapest option
Generic Triumeq (dolutegravir/abacavir/lamivudine) is the most affordable option at $2,800.00 per claim. At the other end, Biktarvy costs $3,746.00 per claim. HIV drugs remain expensive because patent protection is strong and patients require lifelong treatment. Generic Triumeq launched recently at ~$2,800/month. Biktarvy ($3,746/claim) has no generic expected before 2033. Patient assistance programs cover most uninsured patients. See all HIV Antiretrovirals drugs and prices →
When the cheaper option may not work: This class treats serious conditions where specific drug selection is critical. Your doctor may need to prescribe a particular drug based on your specific diagnosis, resistance testing, or treatment history. Do not switch without medical guidance.
Statins (Cholesterol-Lowering)
HMG-CoA reductase inhibitors that lower LDL cholesterol. The most widely prescribed drug class in America.
Cheapest Option
Atorvastatin (generic Lipitor)
$16.00/claim
Most Expensive
Repatha
$757.00/claim
Potential savings: $741.00 per claim by choosing the cheapest option
The cheapest option in this class is Atorvastatin (generic Lipitor) at $16.00 per claim — a generic that is widely available and well-established. The most expensive option, Repatha, costs $757.00 per claim. Switching from Repatha ($757/claim) to generic atorvastatin ($16/claim) saves $741 per fill — though PCSK9 inhibitors like Repatha target a different mechanism and may be necessary when statins alone are insufficient. See all Statins (Cholesterol-Lowering) drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
GLP-1 Receptor Agonists (Weight Loss & Diabetes)
The most talked-about drug class in America. GLP-1s treat Type 2 diabetes and obesity, with blockbuster drugs like Ozempic, Wegovy, and Mounjaro.
Cheapest Option
Compounded semaglutide (not FDA-approved generic)
$149.00/claim
Most Expensive
Zepbound
$867.00/claim
Potential savings: $718.00 per claim by choosing the cheapest option
Compounded semaglutide (not FDA-approved generic) is the most affordable option at $149.00 per claim. At the other end, Zepbound costs $867.00 per claim. No FDA-approved generics exist yet. Medicare negotiated Ozempic/Wegovy/Rybelsus to $274/month for 2027 (71% off list price). Compounded semaglutide costs $149-299/month but faces FDA scrutiny. TrumpRx offers Ozempic at $199-350 for 43 drugs. See all GLP-1 Receptor Agonists (Weight Loss & Diabetes) drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Diabetes Medications
Includes insulin, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and metformin. The highest-growth drug class by Medicare spending.
Cheapest Option
Metformin (generic Glucophage)
$4.00/claim
Most Expensive
Ozempic
$685.00/claim
Potential savings: $681.00 per claim by choosing the cheapest option
The cheapest option in this class is Metformin (generic Glucophage) at $4.00 per claim — a generic that is widely available and well-established. The most expensive option, Ozempic, costs $685.00 per claim. Metformin ($4/month) remains the first-line treatment for Type 2 diabetes. Newer GLP-1 agonists cost $400-900/month but Medicare has negotiated Ozempic down to $274/month starting 2027 — a 71% discount. See all Diabetes Medications drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Blood Thinners (Anticoagulants)
Direct oral anticoagulants (DOACs) and traditional blood thinners that prevent blood clots, stroke, and pulmonary embolism.
Cheapest Option
Warfarin (generic Coumadin)
$8.00/claim
Most Expensive
Eliquis
$510.00/claim
Potential savings: $502.00 per claim by choosing the cheapest option
The cheapest option in this class is Warfarin (generic Coumadin) at $8.00 per claim — a generic that is widely available and well-established. The most expensive option, Eliquis, costs $510.00 per claim. Eliquis ($510/claim) is the #1 drug by total Medicare spending ($16.5B). Its Medicare-negotiated price drops 43% in 2026 to ~$291/claim. Generic apixaban could launch in 2028. Warfarin ($8/month) works but requires blood monitoring. See all Blood Thinners (Anticoagulants) drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Blood Pressure Medications (Antihypertensives)
Multiple drug classes treat hypertension: ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, and diuretics. Most are available as cheap generics.
Cheapest Option
Lisinopril (generic Prinivil/Zestril)
$6.00/claim
Most Expensive
Edarbi
$144.00/claim
Potential savings: $138.00 per claim by choosing the cheapest option
The cheapest option in this class is Lisinopril (generic Prinivil/Zestril) at $6.00 per claim — a generic that is widely available and well-established. The most expensive option, Edarbi, costs $144.00 per claim. Almost every first-line blood pressure drug is available as a generic under $10/month. Brand-name ARBs like Edarbi ($144/claim) offer no proven benefit over generic losartan ($9/claim). See all Blood Pressure Medications (Antihypertensives) drugs and prices →
When the cheaper option may not work: Some patients respond better to specific drugs within the class, or may have contraindications based on other medications or health conditions. Your doctor can evaluate whether the cheaper option is appropriate for you.
Summary: Cheapest Drug in Every Class
The table below shows the single cheapest option in each of the 11 drug classes tracked on DrugPrice, based on Medicare Part D average cost per claim.
| Drug Class | Cheapest Drug | Cost/Claim | Most Expensive | Cost/Claim | Savings |
|---|---|---|---|---|---|
| Multiple Sclerosis (MS) Treatments | Generic dimethyl fumarate (Tecfidera generic) | $800.00 | Ocrevus | $23,635.00 | $22,835.00 |
| Cancer Immunotherapy & Targeted Therapy | Generic ibrutinib (Imbruvica biosimilar) | $6,500.00 | Keytruda | $18,176.00 | $11,676.00 |
| Biologics for Autoimmune Diseases | Humira biosimilars (Hadlima, Hyrimoz, etc.) | $1,200.00 | Stelara | $7,763.00 | $6,563.00 |
| Asthma & COPD Inhalers | Generic albuterol inhaler | $25.00 | Nucala | $2,720.00 | $2,695.00 |
| Antidepressants (SSRIs, SNRIs & Newer Agents) | Sertraline (generic Zoloft) | $4.00 | Spravato | $1,839.00 | $1,835.00 |
| HIV Antiretrovirals | Generic Triumeq (dolutegravir/abacavir/lamivudine) | $2,800.00 | Biktarvy | $3,746.00 | $946.00 |
| Statins (Cholesterol-Lowering) | Atorvastatin (generic Lipitor) | $16.00 | Repatha | $757.00 | $741.00 |
| GLP-1 Receptor Agonists (Weight Loss & Diabetes) | Compounded semaglutide (not FDA-approved generic) | $149.00 | Zepbound | $867.00 | $718.00 |
| Diabetes Medications | Metformin (generic Glucophage) | $4.00 | Ozempic | $685.00 | $681.00 |
| Blood Thinners (Anticoagulants) | Warfarin (generic Coumadin) | $8.00 | Eliquis | $510.00 | $502.00 |
| Blood Pressure Medications (Antihypertensives) | Lisinopril (generic Prinivil/Zestril) | $6.00 | Edarbi | $144.00 | $138.00 |
Source: CMS Medicare Part D Drug Spending Dashboard. Cost per claim reflects the average total cost (plan + patient share) for approximately a 30-day supply.
How to Ask Your Doctor About Switching to a Cheaper Drug
Most doctors want to help you save money — but they won't know cost is a concern unless you tell them. Here is a practical script for your next appointment:
- Name the drug and the class. "I'm taking [brand drug]. I saw that [generic] is in the same class and costs significantly less."
- Ask directly. "Would switching to [generic] be safe and effective for my condition?"
- Ask about trade-offs. "Are there any differences in side effects or effectiveness I should know about?"
- If they say no, ask why. A good reason might be: you've failed the generic before, the brand has a unique mechanism, or your condition requires that specific drug. A less compelling reason: "it's what I usually prescribe."
- Ask your pharmacist too. Pharmacists can often suggest therapeutic alternatives and may know about manufacturer coupons or discount programs.
Studies show that when patients ask about generic alternatives, doctors switch the prescription approximately 75% of the time. The conversation is worth having — especially when the savings can be hundreds of dollars per month.
When You Cannot Switch to the Cheapest Option
While generic substitution works for most patients, there are important exceptions where you should not simply switch to the cheapest drug in the class:
- Narrow therapeutic index drugs. Medications like warfarin, levothyroxine, and certain anti-seizure drugs have a very narrow range between an effective dose and a dangerous dose. Even small differences between generic manufacturers can matter. Your doctor may specify a particular manufacturer for these drugs.
- Biologics and biosimilars. Biologic drugs (common in autoimmune disease treatment) are complex proteins that cannot be exactly replicated. Biosimilars are highly similar but not identical. Switching biologics mid-treatment should only be done under medical supervision.
- HIV and oncology. Drug resistance patterns, specific mutations, and treatment history often dictate which drug within a class is appropriate. The cheapest option may not target your specific disease variant.
- Mental health medications. If you are stable on an antidepressant or antipsychotic, switching — even within the same class — can trigger relapse or withdrawal symptoms. The cost of instability often outweighs the savings.
- Failed previous trials. If you previously tried the cheaper drug and it did not work or caused intolerable side effects, that is a valid reason to stay on the more expensive option.
The goal is not to always take the cheapest drug — it is to never pay more than necessary for the same clinical outcome. For the majority of patients on common medications like statins, blood pressure drugs, or antidepressants, a generic alternative works just as well at a fraction of the price.
Frequently Asked Questions
Not always. While drugs in the same class work through similar mechanisms, individual response varies. Some patients tolerate one drug better than another, and certain conditions require specific drugs within a class. Always consult your doctor before switching — but it is absolutely worth asking about cheaper alternatives, especially generics.
The biggest factor is patent status. Once a drug loses patent protection, generic manufacturers can produce it for a fraction of the cost. A brand-name drug might cost $500 per claim while its generic equivalent costs $15. Other factors include manufacturing complexity, market competition among generic makers, and whether the drug is a biologic (which are harder to copy).
Be direct: "Is there a generic or lower-cost alternative in the same drug class that would work for my condition?" Bring this price guide to your appointment. Most doctors are receptive — they know cost is a barrier to adherence. If your doctor insists on the brand-name, ask specifically why the cheaper option won't work for your situation.
Yes. The FDA requires generic drugs to have the same active ingredient, strength, dosage form, and route of administration as the brand-name drug. Generics must demonstrate bioequivalence — meaning they deliver the same amount of active ingredient into the bloodstream at the same rate. The only differences are inactive ingredients like fillers and colorings, which rarely affect efficacy.